YERVOY 5 mg/ml concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion, DACARBAZINE
IMCgp100-202
Phase 2 small_molecule active
Quick answer
YERVOY 5 mg/ml concentrate for solution for infusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, KIMMTRAK 100 micrograms/0.5 mL concentrate for solution for infusion, DACARBAZINE for Previously untreated advanced uveal melanoma (UM) is a Phase 2 program (small_molecule) at Immunocore Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Immunocore Ireland Limited
- Indication
- Previously untreated advanced uveal melanoma (UM)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active